Nizatidine and Hyperglycemia - a phase IV clinical study of FDA data

Summary:

Hyperglycemia is reported as a side effect among people who take Nizatidine (nizatidine), especially for people who are female, 60+ old, also take Velcade, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Hyperglycemia when taking Nizatidine. It is created by eHealthMe based on reports of 3,045 people who have side effects when taking Nizatidine from the FDA, and is updated regularly.

What is Nizatidine?

Nizatidine has active ingredients of nizatidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 3,082 Nizatidine users. Check the latest studies of Nizatidine.

What is Hyperglycemia?

Hyperglycemia (high blood sugar) is found to be associated with 1,660 drugs and 2,500 conditions by eHealthMe. Check the latest studies of Hyperglycemia.

On Aug, 05, 2026

3,045 people reported to have side effects when taking Nizatidine.
Among them, 12 people (0.39%) have Hyperglycemia.

Among these 12 people:

What is the gender of people who have Hyperglycemia when taking Nizatidine? *

female: 90 %
male: 10 %

What is the age of people who have Hyperglycemia when taking Nizatidine? *

What are other drugs people take besides Nizatidine? *

Allopurinol: 5 people, 41.67%
Lasix: 5 people, 41.67%
Zometa: 5 people, 41.67%
Velcade: 5 people, 41.67%
Prednisolone: 4 people, 33.33%
Alendronate Sodium: 4 people, 33.33%
Diflucan: 4 people, 33.33%
Rebetol: 4 people, 33.33%
Sulfamethoxazole And Trimethoprim: 3 people, 25.00%
Zopiclone: 1 person, 8.33%

What are other side effects people have besides Hyperglycemia? *

Haemoglobin Decreased: 7 people, 58.33%
Thrombocytopenia (decrease of platelets in blood): 6 people, 50.00%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 5 people, 41.67%
Hyperkalemia (damage to or disease of the kidney): 5 people, 41.67%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 5 people, 41.67%
Pulmonary Infarction (death of a small area of lung): 5 people, 41.67%
Malaise (a feeling of general discomfort or uneasiness): 5 people, 41.67%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 5 people, 41.67%
Anaemia (lack of blood): 5 people, 41.67%
Hypoaesthesia (reduced sense of touch or sensation): 4 people, 33.33%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 6 people, 50.00%
Hepatitis C: 4 people, 33.33%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 4 people, 33.33%
Sleep Disorder: 1 person, 8.33%
Pancreatic Carcinoma Stage Iv (pancreatic cancer stage iv): 1 person, 8.33%
Pain: 1 person, 8.33%
Neuropathy Peripheral (surface nerve damage): 1 person, 8.33%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 8.33%
Insomnia (sleeplessness): 1 person, 8.33%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Nizatidine and have Hyperglycemia?

- Check whether Hyperglycemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nizatidine:

Nizatidine (3,082 reports)

Hyperglycemia treatments and more:

Hyperglycemia (48,691 reports)

Browse all side effects of Nizatidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperglycemia:

Hyperglycemia (1,660 drugs)

Browse all the conditions that are associated with Hyperglycemia:

Hyperglycemia (2,500 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nizatidine (the active ingredients of Nizatidine) and Nizatidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.